Humana's Q3 earnings exceeded estimates at $3.24. Sales rose to $32.65 billion, driven by Medicare premiums. Total medical membership dropped to 14.99 million. Adjusted EPS guidance for 2025 is reaffirmed at $17.00. HUM shares fell 6.56% to $263.37 post-reporting.
Despite beating earnings, declining membership affects investor sentiment similarly to historical trends when companies report strong earnings but declining customer numbers.
The immediate market response reflects short-term investor concerns over declining membership rather than long-term fundamentals.
The earnings surpassed estimates but the drop in membership could influence future growth, making it significant for investors.